- Home
- FNGR vs ADAP Comparison
FNGR vs ADAP Comparison
Compare FNGR & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNGR
- ADAP
- Stock Information
- Founded
- FNGR 2016
- ADAP 2008
- Country
- FNGR Singapore
- ADAP United Kingdom
- Employees
- FNGR N/A
- ADAP N/A
- Industry
- FNGR Computer Software: Prepackaged Software
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- FNGR Technology
- ADAP Health Care
- Exchange
- FNGR Nasdaq
- ADAP Nasdaq
- Market Cap
- FNGR 72.0M
- ADAP 71.6M
- IPO Year
- FNGR N/A
- ADAP 2015
- Fundamental
- Price
- FNGR $1.45
- ADAP $0.21
- Analyst Decision
- FNGR
- ADAP Strong Buy
- Analyst Count
- FNGR 0
- ADAP 5
- Target Price
- FNGR N/A
- ADAP $1.93
- AVG Volume (30 Days)
- FNGR 282.2K
- ADAP 2.4M
- Earning Date
- FNGR 01-14-2025
- ADAP 03-20-2025
- Dividend Yield
- FNGR N/A
- ADAP N/A
- EPS Growth
- FNGR N/A
- ADAP N/A
- EPS
- FNGR N/A
- ADAP N/A
- Revenue
- FNGR $33,570,107.00
- ADAP $178,032,000.00
- Revenue This Year
- FNGR $260.03
- ADAP N/A
- Revenue Next Year
- FNGR N/A
- ADAP $56.87
- P/E Ratio
- FNGR N/A
- ADAP N/A
- Revenue Growth
- FNGR N/A
- ADAP 195.34
- 52 Week Low
- FNGR $1.03
- ADAP $0.20
- 52 Week High
- FNGR $3.96
- ADAP $1.55
- Technical
- Relative Strength Index (RSI)
- FNGR 52.62
- ADAP 14.09
- Support Level
- FNGR $1.55
- ADAP $0.26
- Resistance Level
- FNGR $1.83
- ADAP $0.47
- Average True Range (ATR)
- FNGR 0.14
- ADAP 0.04
- MACD
- FNGR 0.01
- ADAP -0.02
- Stochastic Oscillator
- FNGR 41.54
- ADAP 1.23
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.